InsidersTradesSigma
Track the DEXCOM, INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). The latest transaction was filed on 6 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: KEVIN R SAYER. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
DEXCOM, INC. is a company that specializes in developing continuous glucose monitoring systems for individuals with diabetes. It is listed on the NASDAQ under the symbol DXCM.